The tissue-specific role of mitochondrial respiratory capacity in the development of insulin resistance and type 2 diabetes is unclear. We determined mitochondrial function in glycolytic and oxidative skeletal muscle and liver from lean (ϩ/?) and obese diabetic (db/db) mice. In lean mice, the mitochondrial respiration pattern differed between tissues. Tissuespecific mitochondrial profiles were then compared between lean and db/db mice. In liver, mitochondrial respiratory capacity and protein expression, including peroxisome proliferator-activated receptor-␥ coactivator-1␣ (PGC-1␣), was decreased in db/db mice, consistent with increased mitochondrial fission. In glycolytic muscle, mitochondrial respiration, as well as protein and mRNA expression of mitochondrial markers, was increased in db/db mice, suggesting increased mitochondrial content and fatty acid oxidation capacity. In oxidative muscle, mitochondrial complex I function and PGC-1␣ and mitochondrial transcription factor A (TFAM) protein levels were decreased in db/db mice, along with increased level of proteins related to mitochondrial dynamics. In conclusion, mitochondrial respiratory performance is under the control of tissue-specific mechanisms and is not uniformly altered in response to obesity. Furthermore, insulin resistance in glycolytic skeletal muscle can be maintained by a mechanism independent of mitochondrial dysfunction. Conversely, insulin resistance in liver and oxidative skeletal muscle from db/db mice is coincident with mitochondrial dysfunction. mitochondrial dysfunction; mitochondrial biogenesis; oxidative capacity; energy metabolism OBESITY IS A MAJOR RISK FACTOR for development of insulin resistance and type 2 diabetes mellitus (T2DM) (49). Insulin resistance in skeletal muscle and liver, coupled with -cell failure, represents underlying defects in T2DM. Thus, there is a growing appreciation that defects in insulin action in multiple tissues contribute to whole body insulin resistance, disturbances in energy balance, and T2DM.Mitochondrial dysfunction has been implicated in the development of insulin resistance and the pathogenesis of T2DM (32,37,38). The vast majority of mitochondrial proteins, as well as factors controlling the expression and proliferation of the mitochondrial genome, are encoded in the nucleus. Studies of rodent tissues, including analysis of mitochondrial DNA copy number, cytochrome c oxidase activity, and mitochondrial mass in liver, cardiac muscle, and oxidative and glycolytic skeletal muscle (8,9,14,50,51) provide evidence for marked tissue-specific differences in mitochondrial properties, concurrent with varying metabolic characteristics and demands unique to each specific tissue. Furthermore, quantitative mass spectrometry and 2-D gel electrophoresis of the mitochondrial proteome reveal tissue-specific mitochondrial protein programs (13,24,34). Mitochondria are finely tuned to meet the specific needs of the tissue as well as the environmental or pathophysiological state that the specific tissue encounters (1...